Sandoval Elisabeth 4
4 · VYNE Therapeutics Inc. · Filed Dec 15, 2023
Insider Transaction Report
Form 4
Sandoval Elisabeth
Director
Transactions
- Award
Stock Option (right to buy)
2023-12-13+20,000→ 20,000 totalExercise: $2.70Exp: 2033-12-12→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest on December 13, 2024, subject to the Reporting Person's continuous service through such date.